{"id":9784,"date":"2024-11-27T15:18:58","date_gmt":"2024-11-27T14:18:58","guid":{"rendered":"https:\/\/www.imbc.be\/eonix-va-construire-le-coffre-fort-europeen-de-ladn\/"},"modified":"2024-11-27T15:18:58","modified_gmt":"2024-11-27T14:18:58","slug":"eonix-va-construire-le-coffre-fort-europeen-de-ladn","status":"publish","type":"post","link":"https:\/\/www.imbc.be\/en\/eonix-va-construire-le-coffre-fort-europeen-de-ladn\/","title":{"rendered":"Eonix va construire le coffre-fort europ\u00e9en de l&#8217;ADN !"},"content":{"rendered":"\n<p>Eonix, sp\u00e9cialiste dans l&#8217;informatique de donn\u00e9es sensibles, rel\u00e8ve un nouveau d\u00e9fi en cr\u00e9ant un coffre-fort s\u00e9curis\u00e9 permettant aux citoyens europ\u00e9ens de stocker leur ADN num\u00e9rique en toute s\u00e9curit\u00e9.<\/p>\n\n\n\n<p>Ce stockage permettra d&#8217;effectuer des analyses m\u00e9dicales pouss\u00e9es, des profilages des risques pour des maladies complexes voire rares mais aussi des tests g\u00e9n\u00e9tiques.<\/p>\n\n\n\n<p>A c\u00f4t\u00e9 de ce coffre-fort, Eonix souhaite \u00e9galement mettre en place un syst\u00e8me de d\u00e9pistage du cancer du poumon afin d&#8217;\u00e9viter des surdiagnostics mais aussi des interventions douloureuses sur des personnes saines.<\/p>\n\n\n\n<p>Voir l&#8217;article complet sur <a href=\"https:\/\/www.lecho.be\/entreprises\/pharma-biotechnologie\/eonix-va-construire-le-coffre-fort-europeen-de-l-adn\/10501387.html\">L&#8217;Echo<\/a>, publi\u00e9 le 25 octobre 2023.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Eonix, sp\u00e9cialiste dans l&#8217;informatique de donn\u00e9es sensibles, rel\u00e8ve un nouveau d\u00e9fi en cr\u00e9ant un coffre-fort s\u00e9curis\u00e9 permettant aux citoyens europ\u00e9ens de stocker leur ADN num\u00e9rique en toute s\u00e9curit\u00e9. Ce stockage permettra d&#8217;effectuer des analyses m\u00e9dicales pouss\u00e9es, des profilages des risques pour des maladies complexes voire rares mais aussi des tests g\u00e9n\u00e9tiques. A c\u00f4t\u00e9 de ce [&hellip;]<\/p>\n","protected":false},"author":13,"featured_media":7760,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[261],"tags":[],"class_list":["post-9784","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-presse-en"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.imbc.be\/en\/wp-json\/wp\/v2\/posts\/9784","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.imbc.be\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.imbc.be\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.imbc.be\/en\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/www.imbc.be\/en\/wp-json\/wp\/v2\/comments?post=9784"}],"version-history":[{"count":0,"href":"https:\/\/www.imbc.be\/en\/wp-json\/wp\/v2\/posts\/9784\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.imbc.be\/en\/wp-json\/wp\/v2\/media\/7760"}],"wp:attachment":[{"href":"https:\/\/www.imbc.be\/en\/wp-json\/wp\/v2\/media?parent=9784"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.imbc.be\/en\/wp-json\/wp\/v2\/categories?post=9784"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.imbc.be\/en\/wp-json\/wp\/v2\/tags?post=9784"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}